FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
For Immediate Release: June 15, 2026 On June 12, 2026, the U.S. Food and Drug Administration granted accelerated…